Lord, Abbett & Co. LLC Avidity Biosciences, Inc. Transaction History
Lord, Abbett & Co. LLC
- $31.4 Billion
- Q3 2024
A detailed history of Lord, Abbett & Co. LLC transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Lord, Abbett & Co. LLC holds 539,207 shares of RNA stock, worth $15.9 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
539,207
Previous 539,207
-0.0%
Holding current value
$15.9 Million
Previous $24.8 Million
-0.0%
% of portfolio
0.08%
Previous 0.08%
Shares
2 transactions
Others Institutions Holding RNA
# of Institutions
254Shares Held
107MCall Options Held
224KPut Options Held
161K-
Price T Rowe Associates Inc Baltimore, MD10.6MShares$313 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.23MShares$272 Million0.01% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$254 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY8.13MShares$240 Million5.95% of portfolio
-
Wellington Management Group LLP Boston, MA7.03MShares$207 Million0.06% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $1.54B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...